You are here: Industry Insights > Ibuprofen

News List

Demand for Antipyretic Drug Strikes Again, Restarting the Battle of iBuprofen Lao Xue/PharmaSources
May 29, 2023
Ibuprofen APIs and preparations are once again experiencing sales growth due to the recurrence of COVID-19 after the previous boom of antipyretic drug.
Paracetamol API manufacturers in China PharmaSources
June 04, 2021
Paracetamol, otherwise also known as acetaminophen or more commonly known as PCM is used to treat fever and mild to moderate aches. Paracetamol is a low-cost medication and is widely available around the world.
Ibuprofen Uses, Manufacturing Process and API Manufacturers in China PharmaSources
May 17, 2021
What is in Ibuprofen? Ibuprofen API manufacturers in China; Can I take ibuprofen after the COVID vaccine?
Alkem Laboratories launches Ibuprofen, Famotidine tablets in US expresspharma
August 05, 2021
The company has launched the tablets in the strength of 800 mg/26.6 mg in the United States, following an approval from the US Food and Drug Administration (FDA).
NPPA allows 50% price hike for ibuprofen, ranitidine, carbamazepine firstwordpharma
July 06, 2021
India’s pharmaceutical pricing regulator has allowed a one-time price hike of 50% for ibuprofen, ranitidine and carbamazepine, Business Standard reported.
Strides gets USFDA nod for Ibuprofen OTC Oral Suspension expresspharma
February 25, 2021
Strides Pharma Science announced that its step-down wholly-owned subsidiary, Strides Pharma Global Pte, Singapore, has received approval for Ibuprofen Oral Suspension USP,100 mg/5 mL (OTC) from the United States Food & Drug Administration (USFDA).
Trial for new ibuprofen formulation as COVID-19 treatment launched in UK europeanpharmaceuticalreview
June 16, 2020
A unique formulation of ibuprofen is being tested as a treatment for severe acute respiratory distress syndrome (ARDS), a symptom of COVID-19.
No scientific evidence to establish link between ibuprofen and worsening of Covid-19: Sanofi expresspharma
March 23, 2020
Pharma major Sanofi announced that there is currently no scientific evidence establishing a link between ibuprofen and worsening of COVID-19.
EMA issues statement on ibuprofen reports relating to COVID-19 europeanpharmaceuticalreview
March 20, 2020
The EMA has announced that reports of NSAIDs like ibuprofen making the COVID-19 coronavirus worse have no scientific basis.
Ibuprofen in the first three months of pregnancy may harm future fertility europeanpharmaceuticalreview
April 29, 2019
Researchers have found evidence in human ovarian tissue that exposure to ibuprofen during the first three months of foetal development results in a dramatic loss of the germ cells…

Previous page 1 2 Next page